Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
JPM 2020
Research
Cyclerion drug passes early neurodegenerative disease test
Preclinical studies suggest sGC stimulator IW-6463 can improve dendritic spine density, reduce neuroinflammation and increase brain blood flow.
Angus Liu
Jan 21, 2020 7:45am
JPM: Execs on where the industry should look beyond cancer
Jan 17, 2020 10:05am
In conversation with Steve Paul, CEO of Karuna Therapeutics
Jan 16, 2020 9:15am
Analysts tip Biogen to file for aducanumab approval within weeks
Jan 16, 2020 7:50am
Concerto HealthAI unveils $150M raise, 2 pharma collaborations
Jan 15, 2020 7:50pm
TransEnterix submits digital vision surgery assistant to FDA
Jan 15, 2020 3:30pm
